SCHEMBL9019628

SCHEMBL9019628

COCCOCCOc1ccc(C(=O)O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.68
PKM P14618 1/20 0.66
MAPK1 P28482 2/20 0.58
TSHR P16473 2/20 0.58
TP53 P04637 1/20 0.58
PLA2G4B P0C869 4/20 0.57
MAPT P10636 2/20 0.56
USP2 O75604 1/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
RAB9A P51151 2/20 0.54
HTT P42858 1/20 0.54
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
NPC1 O15118 1/20 0.53
POLB P06746 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
PLA2G4A P47712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13448825 1.00 RARB (0.68) RARBPKMMAPK1TSHRTP53
SCHEMBL9361418 1.00 RARB (0.68) RARBPKMMAPK1TSHRTP53
SCHEMBL15562010 1.00 RARB (0.68) RARBPKMMAPK1TSHRTP53
SCHEMBL2741522 0.95 PKM (0.72) RARBPKMMAPK1TSHRTP53
SCHEMBL21260346 0.93 RARB (0.68) RARBPKMMAPK1TSHRTP53
SCHEMBL577687 0.91 PKM (0.78) RARBPKMMAPK1TSHRTP53
SCHEMBL20502046 0.91 PKM (0.78) RARBPKMMAPK1TSHRTP53
SCHEMBL4509186 0.91 PKM (0.78) RARBPKMMAPK1TSHRTP53
SCHEMBL13918671 0.91 PKM (0.78) RARBPKMMAPK1TSHRTP53
SCHEMBL13861910 0.90 RARB (0.68) RARBPKMMAPK1TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113903864-A Organic solar cell and organic-inorganic heterogeneous interface regulation and control method thereof 浙江大学 2022-01-07 CN claimed
US-20230205083-A1 SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-29 US disclosed
US-20230205083-A1 SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-06-29 US disclosed
CN-113903864-A Organic solar cell and organic-inorganic heterogeneous interface regulation and control method thereof 浙江大学 2022-01-07 CN disclosed
US-10319533-B2 Photoelectric conversion element and solar cell RICOH COMPANY, LTD. (JP) 2019-06-11 US disclosed
US-20180197688-A1 PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL RICOH COMPANY, LTD. (JP) 2018-07-12 US disclosed
US-5518783-A TRANSPARENT SUPPORT HAVING OPTIC AXIS INCLINED AT SPECIFIED ANGLE TO NORMAL, OPTICALLY ANISOTROPIC LAYER FORMED FROM DISCOTIC COMPOUND AND COMPATIBLE COMPOUND WHICH LOWERS TRANSITION TEMPERATURE FUJI PHOTO FILM CO., LTD. (JP) 1996-05-21 US disclosed
EP-0676652-A2 Optical compensatory sheet and liquid crystal display FUJI PHOTO FILM CO., LTD. (JP) 1995-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230205083-A1 SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS SLC6A9, SLC6A5, REN RARB 1762/4885PKM 4304/4885MAPK1 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.